LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance

 

• Total revenues increased 49% year-over-year to $65.7 million with telehealth revenue up 70%
• Adjusted EBITDA increased to $8.7 million from $0.1 million in the year-ago period
• Telehealth adjusted EBITDA increased to $5.3 million from a loss of $1.3 million in the year-ago period
• GAAP net income of $0.6 million or $0.01 per diluted share, delivering first-ever quarter of positive GAAP EPS
• Raising full-year 2025 guidance for both total revenues and adjusted EBITDA, reflecting strong year-to-date performance in telehealth
  

Conference call begins at 4:30 p.m. Eastern time today

LifeMD’s management will host a conference call today at 4:30 p.m. Eastern time to discuss the Company’s financial results and outlook, and answer questions. Details for the call are as follows:

Toll-free dial-in number:	800-225-9448
International dial-in number:	203-518-9708
Conference ID:	LIFEMD
Live & Archived Webcast:	Link

A live and archived webcast will be available in the Investors section of the Company’s website at ir.lifemd.com.

https://www.globenewswire.com/news-release/2025/05/06/3075516/6480/en/LifeMD-Reports-First-Quarter-2025-Results-and-Raises-Full-Year-2025-Guidance.html